Works matching IS 00278874 AND DT 2012 AND VI 104 AND IP 12
Results: 20
Re: Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Non-Hodgkin lymphoma in early life.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Effect of ADAM28 on Carcinoma Cell Metastasis by Cleavage of von Willebrand Factor.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Perinatal and Family Risk Factors for Non-Hodgkin Lymphoma in Early Life: A Swedish National Cohort Study.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 923, doi. 10.1093/jnci/djs225
- By:
- Publication type:
- Article
Administrative Data Algorithms to Identify Second Breast Cancer Events Following Early-Stage Invasive Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 931, doi. 10.1093/jnci/djs233
- By:
- Publication type:
- Article
Effect of ADAM28 on Carcinoma Cell Metastasis by Cleavage of von Willebrand Factor.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 906, doi. 10.1093/jnci/djs232
- By:
- Publication type:
- Article
Probing the Mechanism of ADAM28-Mediated Cancer Metastasis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 00, doi. 10.1093/jnci/djs300
- Publication type:
- Article
Cover.
- Published in:
- 2012
- Publication type:
- Cover Art
New Wrinkle Between Cancer and Blood Coagulation: Metastasis and Cleavage of von Willebrand Factor by ADAM28.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Re: Predictability of Adjuvant Trastuzumab Benefit in N9831 Patients Using the ASCO/CAP HER2-Positivity Criteria.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Non-Hodgkin Lymphoma in Early Life.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 888, doi. 10.1093/jnci/djs252
- By:
- Publication type:
- Article
Cancer Stem Cells: Getting to the Root of Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 893, doi. 10.1093/jnci/djs292
- By:
- Publication type:
- Article
Response.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 958, doi. 10.1093/jnci/djs244
- By:
- Publication type:
- Article
Role of the Tripartite Motif Protein 27 in Cancer Development.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 941, doi. 10.1093/jnci/djs224
- By:
- Publication type:
- Article
The Plight of Childhood Cancers for Families.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 897, doi. 10.1093/jnci/djs295
- By:
- Publication type:
- Article
Early-life Risk Factors for Non-Hodgkin Lymphoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 1, doi. 10.1093/jnci/djs282
- Publication type:
- Article
Neovascularization After Irradiation: What is the Source of Newly Formed Vessels in Recurring Tumors?
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 899, doi. 10.1093/jnci/djs239
- By:
- Publication type:
- Article
Intraoperative Radiotherapy Makes Uncertain Headway in the U.S.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 895, doi. 10.1093/jnci/djs294
- By:
- Publication type:
- Article
Risk of Non-Melanoma Cancers in First-Degree Relatives of CDKN2A Mutation Carriers.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 953, doi. 10.1093/jnci/djs221
- By:
- Publication type:
- Article
Drug Shortages Delay Cancer Clinical Trials.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2012, v. 104, n. 12, p. 891, doi. 10.1093/jnci/djs293
- By:
- Publication type:
- Article